Zobrazeno 1 - 10
of 95
pro vyhledávání: '"A. Parneix-Spake"'
Autor:
Warshaw, Erin M., Wohlhuter, Ross Jon, Liu, An, Zeller, Sarah A., Wenner, Rachel A., Bowers, Sacharitha, Schultz, Julie C., Katz, H. Irving, McCormick, Calogera L., Parneix-Spake, Anne
Publikováno v:
In Journal of the American Academy of Dermatology 2007 57(2):257-264
Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: A double-blind, randomized study
Autor:
Gribetz, Carin, Ling, Mark, Lebwohl, Mark, Pariser, David, Draelos, Zoe, Gottlieb, Alice B., Zaias, Nardo, Chen, Diana M., Parneix-Spake, Anne, Hultsch, Thomas, Menter, Alan
Publikováno v:
In Journal of the American Academy of Dermatology November 2004 51(5):731-738
Publikováno v:
Journal of Dermatological Treatment. Dec2001, Vol. 12 Issue 4, p191-197. 7p. 3 Graphs.
Publikováno v:
Dermatitis. 18:134-139
BACKGROUND The low concentration of propylene glycol (PG) in pimecrolimus cream makes it unlikely that the cream will induce a PG-related irritant or allergic contact dermatitis. OBJECTIVE To assess reactions to pimecrolimus cream in patients who are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00a107d83e20ed27a502631c2aef09a1
https://doi.org/10.2310/6620.2007.06028
https://doi.org/10.2310/6620.2007.06028
Autor:
Adelaide A Hebert, Thomas Hultsch, P. R. Gallagher, C. McCormick, Anne Parneix-Spake, Jonathan M. Spergel, Mark Boguniewicz, Amy S. Paller
Publikováno v:
British Journal of Dermatology. 157:378-381
Summary Background Combination therapy with pimecrolimus cream 1%, a topical calcineurin inhibitor (TCI), and fluticasone propionate cream 0·05% (FP), a mid-potency topical corticosteroid, may have a synergistic effect for treatment of atopic dermat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbad728b54ef5756f6d70bfb0c23c1cb
https://doi.org/10.1111/j.1365-2133.2007.08001.x
https://doi.org/10.1111/j.1365-2133.2007.08001.x
Autor:
Erin M. Warshaw, Sarah A. Zeller, Julie C. Schultz, Calogera L. McCormick, Ross Jon Wohlhuter, An Liu, H. Irving Katz, Sacharitha Bowers, Anne Parneix-Spake, Rachel A. Wenner
Publikováno v:
Journal of the American Academy of Dermatology. 57:257-264
Background Seborrheic dermatitis is commonly treated with anti-inflammatory products, including topical corticosteroids. Pimecrolimus cream 1% also exerts anti-inflammatory activity by inhibiting T-cell cytokine production. Objective We sought to com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8cea1f00ea51037e8d37b6e279223af
https://doi.org/10.1016/j.jaad.2006.11.007
https://doi.org/10.1016/j.jaad.2006.11.007
Publikováno v:
International Journal of Dermatology. 46:700-705
Background Use of topical corticosteroids for the treatment of pityriasis alba is limited by their potential side-effects, such as skin atrophy especially with long-term use on the face. Pimecrolimus cream 1% is a topical calcineurin inhibitor that h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f577ffa76c36505e05a611dabffd8022
https://doi.org/10.1111/j.1365-4632.2007.03145.x
https://doi.org/10.1111/j.1365-4632.2007.03145.x
Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: A double-blind, randomized study
Autor:
Alan Menter, Alice B. Gottlieb, Zoe Diana Draelos, Mark Ling, Carin H. Gribetz, Thomas Hultsch, Nardo Zaias, Mark Lebwohl, Anne Parneix-Spake, Diana M. Chen, David M. Pariser
Publikováno v:
Journal of the American Academy of Dermatology. 51:731-738
Background Inverse psoriasis can be difficult to treat because of the high sensitivity of intertriginous areas to cutaneous side effects, such as irritation and striae. Pimecrolimus, a well-tolerated, nonatrophogenic, skin-selective inflammatory cyto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fb47e7fa466a5b12c539365f5b092eb
https://doi.org/10.1016/j.jaad.2004.06.010
https://doi.org/10.1016/j.jaad.2004.06.010
Autor:
Ji Zhang, I De Lepeleire, Paul J. Deutsch, Susan X. Li, A. Parneix-Spake, T Laethem, M. Guillaume, D. Musson, Anup K. Majumdar, Jacqueline B. McCrea, D. Rogers
Publikováno v:
Antimicrobial Agents and Chemotherapy. 47:1439-1442
The penetration of 1 g of intravenous ertapenem once daily for 3 days in suction-induced skin blisters was evaluated. Ten forearm blisters were formed ( n = 12) 12 h prior to the last dose. Concentrations of ertapenem in blister fluid exceeded 4 μg/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86a8ba052d7c27162213a35c86a7c093
https://doi.org/10.1128/aac.47.4.1439-1442.2003
https://doi.org/10.1128/aac.47.4.1439-1442.2003
Autor:
Janine Wechsler, Jean-Pierre Farcet, Martine Bagot, Marie-Helene Delfau, Friedmann D, Anne Parneix-Spake, J. Revuz, Eric Estève, Loïc Vaillant, de Muret A
Publikováno v:
Archives of Dermatology. 131:1009-1015
Background and design Cutaneous pleomorphic small T-cell lymphoma is a rare, recently recognized lymphoma, different from mycosis fungoides and Sezary syndrome. Only a few cases have been reported and no treatment modalities have been defined. We rev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75494d89bb748cd9f16039a03528ac3a
https://doi.org/10.1001/archderm.131.9.1009
https://doi.org/10.1001/archderm.131.9.1009